In London, AstraZeneca shares are down 2.2% at £82.40 after Bloomberg News reported on Sunday that the British drugmaker – which recently became Britain’s biggest company by stock market value – had approached US rival Gilead Sciences about a potential merger of the two companies.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:
What sanction has been handed to your employee for this disgrace ?
Germany are So intertwined with dictator state under Xi.... Soon they will loose all mfg to cheapsters
Us data was manipulated. Unemployment went up, not down. They 'forgot' to count the several million that stopped looking etc.
Bring on the Nukes... 🔥🤪 botn